Company Filing History:
Years Active: 2017
Title: Hanne Therese Bonge-Hansen: Innovating in Radio-pharmaceuticals
Introduction: Hanne Therese Bonge-Hansen, an accomplished inventor based in Oslo, Norway, has made significant contributions to the field of radio-pharmaceuticals. With one notable patent to her name, she exemplifies the spirit of innovation and scientific advancement.
Latest Patents: Hanne’s patent focuses on radio-pharmaceutical complexes, specifically a tissue-targeting complex that comprises a tissue targeting moiety, an octadentate hydroxypyridinone-containing ligand featuring four HOPO moieties, and the ion of an alpha-emitting thorium radionuclide. A distinctive aspect of her invention is the substitution at the N-position of at least one of the four HOPO moieties with a hydroxyalkyl solubilizing group, marking a novel approach in targeting tissues effectively for therapeutic purposes.
Career Highlights: Hanne is currently associated with Bayer AS, a global leader in the life sciences sector. Her innovative work in radio-pharmaceuticals reflects her commitment to enhancing medical technologies and patient care. Throughout her career, Hanne has also collaborated with notable professionals in her field.
Collaborations: One of her key collaborators is Olav B Ryan, with whom she has worked closely in her research endeavors at Bayer AS. Their combined expertise aims to push the boundaries of what's possible in the development of advanced medical treatments.
Conclusion: Hanne Therese Bonge-Hansen's innovative contributions to the field of radio-pharmaceuticals underscore the vital role of inventors in scientific research and development. With her patent and ongoing work at Bayer AS, she continues to pave the way for new therapies that will positively impact patient health and treatment outcomes.